AI is transforming how we understand and treat disease—not just by speeding up development, but by unlocking deeper insights into human biology through massive, diverse datasets. This panel will explore how life sciences companies are using AI, molecular engineering, and real-world data to advance precision medicine. From identifying the right treatments for the right patients to designing personalized therapies for complex and rare conditions, we’ll dive into what’s working today, where the science is heading, and what it means for patients in this new era of care.